BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18951434)

  • 21. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
    Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
    Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study.
    Nuchtern JG; London WB; Barnewolt CE; Naranjo A; McGrady PW; Geiger JD; Diller L; Schmidt ML; Maris JM; Cohn SL; Shamberger RC
    Ann Surg; 2012 Oct; 256(4):573-80. PubMed ID: 22964741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group.
    Monclair T; Mosseri V; Cecchetto G; De Bernardi B; Michon J; Holmes K
    Pediatr Blood Cancer; 2015 Sep; 62(9):1536-42. PubMed ID: 25663103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroblastoma in Iran: an experience of 32 years at a referral childrens hospital.
    Mehdiabadi GB; Arab E; Rafsanjani KA; Ansari S; Moinzadeh AM
    Asian Pac J Cancer Prev; 2013; 14(5):2739-42. PubMed ID: 23803024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presenting features and treatment outcome of 78 Malaysian children with neuroblastoma.
    Ng SM; Abdullah WA; Lin HP; Chan LL
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):149-53. PubMed ID: 10695803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifocal neuroblastoma: biologic behavior and surgical aspects.
    Hiyama E; Yokoyama T; Hiyama K; Yamaoka H; Matsuura Y; Nishimura Si; Ueda K
    Cancer; 2000 Apr; 88(8):1955-63. PubMed ID: 10760774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study.
    Moreau LA; McGrady P; London WB; Shimada H; Cohn SL; Maris JM; Diller L; Look AT; George RE
    Clin Cancer Res; 2006 Oct; 12(19):5693-7. PubMed ID: 17020972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral adrenal neuroblastoma.
    Zaizen Y; Suita S; Yamanaka K; Nagoshi M; Tsuda T
    Eur J Pediatr Surg; 1997 Oct; 7(5):304-7. PubMed ID: 9402493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on MYCN gene amplification and CD44 expression in neuroblastoma].
    Hu HL; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):332-6. PubMed ID: 15363318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.
    Spitz R; Hero B; Ernestus K; Berthold F
    Med Pediatr Oncol; 2003 Jul; 41(1):30-5. PubMed ID: 12764740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of biologic factors on the surgical decision in advanced neuroblastoma.
    Hsu WM; Jen YM; Lee H; Kuo ML; Tsao PN; Chen CN; Lai DM; Lin MT; Lai HS; Chen WJ; Hsieh FJ
    Ann Surg Oncol; 2006 Feb; 13(2):238-44. PubMed ID: 16418884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity.
    Chandrasekar T; Goldberg H; Klaassen Z; Wallis CJD; Woon DTS; Herrera-Caceres JO; Kulkarni GS; Fleshner NE
    Cancer; 2019 Apr; 125(7):1050-1059. PubMed ID: 30561782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating methylated-DCR2 gene in serum as an indicator of prognosis and therapeutic efficacy in patients with MYCN nonamplified neuroblastoma.
    Yagyu S; Gotoh T; Iehara T; Miyachi M; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tamura S; Tsuchiya K; Imamura T; Misawa-Furihata A; Sugimoto T; Sawada T; Hosoi H
    Clin Cancer Res; 2008 Nov; 14(21):7011-9. PubMed ID: 18980997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuroblastoma in children under than 1 year of age].
    Castel Sánchez V; Melero Moreno C; García-Miguel García-Rosados P; Navajas Gutiérrez A; Ruiz Jiménez JI; Navarro Fos S; Garín Valle JC; Galbe Sada M
    An Esp Pediatr; 1997 Dec; 47(6):584-90. PubMed ID: 9575117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification.
    Schleiermacher G; Michon J; Huon I; d'Enghien CD; Klijanienko J; Brisse H; Ribeiro A; Mosseri V; Rubie H; Munzer C; Thomas C; Valteau-Couanet D; Auvrignon A; Plantaz D; Delattre O; Couturier J;
    Br J Cancer; 2007 Jul; 97(2):238-46. PubMed ID: 17579628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biology of neuroblastomas that were found by mass screening at 6 months of age in Japan.
    Kaneko Y; Kobayashi H; Watanabe N; Tomioka N; Nakagawara A
    Pediatr Blood Cancer; 2006 Mar; 46(3):285-91. PubMed ID: 16078225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group.
    Castleberry RP; Shuster JJ; Smith EI
    J Clin Oncol; 1994 Nov; 12(11):2378-81. PubMed ID: 7964953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.
    Weber A; Imisch P; Bergmann E; Christiansen H
    J Clin Oncol; 2004 Jul; 22(13):2681-90. PubMed ID: 15226335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome.
    Kim DK; Alvarado CS; Abramowsky CR; Gu L; Zhou M; Soe MM; Sullivan K; George B; Schemankewitz E; Findley HW
    Pediatr Dev Pathol; 2005; 8(6):621-9. PubMed ID: 16328668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.